Ilyang Pharm (Korea) Technical Analysis
| 007570 Stock | 11,300 80.00 0.71% |
As of the 29th of November, Ilyang Pharm retains the Market Risk Adjusted Performance of 3.4, risk adjusted performance of (0.21), and Standard Deviation of 1.39. Ilyang Pharm technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Ilyang Pharm Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ilyang, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IlyangIlyang |
Ilyang Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Ilyang Pharm Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Ilyang Pharm volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Ilyang Pharm Trend Analysis
Use this graph to draw trend lines for Ilyang Pharm. You can use it to identify possible trend reversals for Ilyang Pharm as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Ilyang Pharm price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Ilyang Pharm Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Ilyang Pharm applied against its price change over selected period. The best fit line has a slop of 42.02 , which may suggest that Ilyang Pharm market price will keep on failing further. It has 122 observation points and a regression sum of squares at 6.679010142E7, which is the sum of squared deviations for the predicted Ilyang Pharm price change compared to its average price change.About Ilyang Pharm Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Ilyang Pharm on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Ilyang Pharm based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Ilyang Pharm price pattern first instead of the macroeconomic environment surrounding Ilyang Pharm. By analyzing Ilyang Pharm's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Ilyang Pharm's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Ilyang Pharm specific price patterns or momentum indicators. Please read more on our technical analysis page.
Ilyang Pharm November 29, 2024 Technical Indicators
Most technical analysis of Ilyang help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ilyang from various momentum indicators to cycle indicators. When you analyze Ilyang charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.21) | |||
| Market Risk Adjusted Performance | 3.4 | |||
| Mean Deviation | 1.02 | |||
| Coefficient Of Variation | (355.58) | |||
| Standard Deviation | 1.39 | |||
| Variance | 1.95 | |||
| Information Ratio | (0.37) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | 3.39 | |||
| Maximum Drawdown | 7.49 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 2.0 | |||
| Skewness | (0.08) | |||
| Kurtosis | 0.8659 |
Complementary Tools for Ilyang Stock analysis
When running Ilyang Pharm's price analysis, check to measure Ilyang Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilyang Pharm is operating at the current time. Most of Ilyang Pharm's value examination focuses on studying past and present price action to predict the probability of Ilyang Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilyang Pharm's price. Additionally, you may evaluate how the addition of Ilyang Pharm to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |